New Yale study evaluates PAXLOVID's use in Long COVID recovery

 Yale School of Medicine announces the initiation of a novel, randomized trial that will test whether receiving PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) for 15 days can improve the health of highly symptomatic adults with Long COVID.